Ronald Chen, M.D., MPH, FASCO, FASTRO

Dr. Chen is an internationally-recognized expert in prostate cancer and bladder cancer. He has written several national guidelines for the American Urological Association (AUA) and the American Society of Clinical Oncology (ASCO) on the treatment of prostate cancer, and is frequently asked to speak across the US and internationally about the latest advances in taking care of prostate and bladder cancer patients. He has also written several textbooks and book chapters on prostate and bladder cancers -- which are read by urologists, radiation oncologists, medical oncologists and students internationally. Dr. Chen is a radiation oncologist with expertise in all forms of radiation treatment, including brachytherapy (seeds), external beam radiation (IMRT, IGRT), and stereotactic body radiation.

Dr. Chen's research focuses on improving treatments and cure rates for patients with the most aggressive cancers, and on reducing side effects and improving quality of life for patients after treatment. He leads several national and international clinical trials in prostate, bladder and testicular cancers. Dr. Chen has received many research grants from the National Cancer Institute, Department of Defense, and Patient-Centered Outcomes Research Institute for his research. He has published more than 170 peer-reviewed articles, many in the most prestigious medical journals.

A prospective comparative study of outcomes with proton and photon radiation for prostate cancer

A study to evaluate cardiovascular risk factors and receipt of primary and preventive care in prostate cancer patients who receive definitive radiation therapy and androgen deprivation therapy

Comparative effectiveness of endocrine therapy and radiation therapy regimens for geriatric breast cancer patients with suboptimal adherence